Submitted by Anonymous (not verified) on 22 April 2024 - 15:00
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 13, Status: Authorised